FORECASTING THE PREVALENCE OF PRE-CLINICAL AND CLINICAL ALZHEIMER’S DISEASE IN THE UNITED STATES

Documenti analoghi

• Impact of Interventions to Reduce Alzheimer’s Disease Pathology on the Prevalence of Dementia in the Oldest-Old
  di: Brookmeyer, Ron, et al.
  Pubblicazione: (2016)
• National estimates of the prevalence of Alzheimer's disease in the United States*
  di: Brookmeyer, Ron, et al.
  Pubblicazione: (2011)
• Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.
  di: Brookmeyer, R, et al.
  Pubblicazione: (1998)
• Lifetime Risks of Alzheimer’s Disease Dementia Using Biomarkers for Preclinical Disease
  di: Brookmeyer, Ron, et al.
  Pubblicazione: (2018)
• Reduced risk of Alzheimer’s disease with high folate intake: The Baltimore Longitudinal Study of Aging
  di: Corrada, María M., et al.
  Pubblicazione: (2005)